Janus Henderson Group PLC lessened its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 22.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,431,193 shares of the company's stock after selling 717,723 shares during the period. Janus Henderson Group PLC owned 0.93% of Ryan Specialty worth $155,985,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of RYAN. Rakuten Securities Inc. bought a new position in Ryan Specialty during the 4th quarter valued at about $27,000. Kapitalo Investimentos Ltda purchased a new stake in Ryan Specialty in the 4th quarter worth approximately $36,000. Principal Securities Inc. boosted its stake in Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after purchasing an additional 415 shares during the period. Mizuho Bank Ltd. bought a new position in shares of Ryan Specialty during the 4th quarter valued at approximately $49,000. Finally, Headlands Technologies LLC boosted its position in shares of Ryan Specialty by 2,644.8% during the 4th quarter. Headlands Technologies LLC now owns 796 shares of the company's stock valued at $51,000 after acquiring an additional 767 shares during the last quarter. Institutional investors own 84.82% of the company's stock.
Insider Activity at Ryan Specialty
In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is owned by corporate insiders.
Ryan Specialty Price Performance
Shares of RYAN stock traded up $0.80 during trading hours on Friday, hitting $70.67. 672,673 shares of the company's stock were exchanged, compared to its average volume of 981,555. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a market cap of $18.55 billion, a P/E ratio of 102.42, a P/E/G ratio of 1.19 and a beta of 0.68. The firm has a 50 day moving average of $70.16 and a two-hundred day moving average of $68.75. Ryan Specialty Holdings, Inc. has a fifty-two week low of $52.34 and a fifty-two week high of $77.16.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting the consensus estimate of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $690.17 million during the quarter, compared to the consensus estimate of $680.80 million. During the same period in the prior year, the company earned $0.35 EPS. The firm's revenue was up 25.0% compared to the same quarter last year. Sell-side analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.
Ryan Specialty Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 0.68%. The ex-dividend date is Tuesday, May 13th. Ryan Specialty's dividend payout ratio is currently 141.18%.
Wall Street Analyst Weigh In
RYAN has been the subject of a number of analyst reports. TD Cowen initiated coverage on Ryan Specialty in a research report on Thursday, April 10th. They issued a "buy" rating and a $89.00 price target for the company. UBS Group raised their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Keefe, Bruyette & Woods reduced their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Barclays dropped their price target on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Finally, Wells Fargo & Company dropped their price target on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $76.42.
Get Our Latest Analysis on RYAN
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
